Jan 30 (Reuters) - INITIATOR PHARMA A/S:
* INITIATOR PHARMA RECEIVES AN INTENTION TO GRANT NOTICE IN EUROPE FOR ITS PIPELINE PRODUCT CANDIDATE IPDP2015 FOR TREATMENT OF DEPRESSION
* SAYS ‍PATENT, WHEN GRANTED, PROVIDES PROTECTION OF IPDP2015 IN EUROPE UNTIL 2029​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)
 